Bibliografía del artículo
1. Kuo D, Ding J, Cohn IS, Zhang F, Wei K, Rao DA, Sokhi UK, Shanaj S, Oliver DJ, Echeverria AP, DiCarlo EF, Brenner MB, Bykerk VP, Goodman SM, Raychaudhuri S, Ratsch G, Ivashkiv LB, Donlin LT. HBEGF macrophages in rheumatoid arthritis induce fibroblast invasiveness. Science Translational Medicine 11:1-13, 2019.
2. Fredman G, Tabas I. Boosting inflammation resolution in atherosclerosis: the next frontier for therapy. The American Journal of Pathology 187:1211-1221, 2017.
3.Mantovani A. The inflammation-cancer connection. The FEBS Journal 285:638-640, 2018.
4. Flores BM, O'Connor A, Moss AC. Impact of mucosal inflammation on risk of colorectal neoplasia in patients with ulcerative colitis: a systematic review and meta-analysis. Gastrointestinal Endoscopy 86:1006-1011, 2017.
5. Cianferoni A, Spergel J. Eosinophilic esophagitis: a comprehensive review. Clinc Rev Allerg Immunol 50:159-174, 2016.
6. Guo CG, Leung WK. Potential strategies in the prevention of nonsteroidal anti-inflammatory drugs-associated adverse effects in the lower gastrointestinal tract. Gut and Liver 14:179, 2020.
7. Scheiman JM. NSAID-induced gastrointestinal injury. Journal of Clinical Gastroenterology 50:5-10, 2016.
8. Sevinsky RE, Stewart DW, Harirforoosh S. Nonsteroidal anti-inflammatory drugs: Is there a link between cardiovascular and renal adverse effects? Journal of Integrative Nephrology and Andrology 4:1, 2017.
9. Gerbino PP. Emerging evidence in NSAID pharmacology: important considerations for product selection. Am J Manag Care 21:S139-S147, 2015.
10. Tziona P, Theodosis-Nobelos P, Rekka E. Medicinal chemistry approaches of controlling gastrointestinal side effects of non-steroidal anti-inflammatory drugs. Endogenous protective mechanisms and drug design. Medicinal Chemistry 13 408-420, 2017.
11. Sukumaran S, Pittman KB, Patterson WK, Dickson J, Yeend S, Townsend A, Broadbridge V, Price TJ. A phase I study to determine the safety, tolerability and maximum tolerated dose of green-lipped mussel (Perna canaliculus) lipid extract, in patients with advanced prostate and breast cancer. Annals of Oncology 21:1089-1093, 2010.
12. Cegielska-Perun K, Marczuk E, Bujalska-Zadroøny M. Novel inhibitors of leukotrienes synthesis in a treatment of inflammatory pain. Acta Poloniae Pharmaceutica 74:1043, 2017.
13. Rodriguez BO, Legleu CEC, De León Fierro LG, Sosa KFC, Luján RC, Longoria RJN. Suplementos nutricionales en el tratamiento y la prevención del dolor muscular tardío: una revisión sistemática. Retos 35: 407, 2019.
14. González V, Sierra R, Mas R, Pérez Y, Oyarzábal A, Rodríguez E, Molina V, Menéndez RG. Patent No. WO 2013/189467 A2. (2015).
15. Pérez Y, Oyarzábal A, Sierra R, Mas R, Molina V, Jiménez S, González V. Inhibition of cyclooxygena se (COX) and 5-lipoxygenase (5-LOX) by D-005 (A lipid extract of Acrocomia crispa fruits). Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas, 16:319-328, 2017.
16. Ravelo Y, Molina V, Jiménez S, Oyarzábal A, Pérez Y, Más R. Effect of oral administration of D-004, a lipid extract from Roystonea regia fruits, on xylene-induced ear oedema in mice. Lat Am J Pharm 30: 1744-1748, 2011.
17. Oyarzábal A, Molina V, Ravelo Y, Pérez Y, Jiménez J. Effects of D-004, a lipid extract of the Roystonea regia fruits, on carrageenan-induced pleurisy in rats. BAOJ Pharm Sci 3:046, 2017.
18. Zamora Z, Molina V, Mena L, Nodal C. Efecto anti-inflamatorio de la terapia combinada del D-002 y lyprinol en un modelo de inflamación crónica. Revista CENIC. Ciencias Biológicas 48:6, 2017.
19. Manual WE. Worthington Biochemical Corp. Freehold, NJ, 43 (1972).
20. Markwell MAK, Haas SM, Bieber LL, Tolbert N. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Analytical Biochemistry 87:206, 1978.
21. Eidi A, Oryan S, Zaringhalam J, Rad M. Antinociceptive and anti-inflammatory effects of the aerial parts of Artemisia dracunculus in mice. Pharmaceutical Biology 54:549, 2016.
22. Wang J. Neutrophils in tissue injury and repair. Cell and Tissue Research 371:531, 2018.
23. Lee YY, Saba E, Irfan M, Kim M, Yi-Le Chan J, Jeon BS, Choi SK, Rhee MH. The anti-inflammatory and anti-nociceptive effects of Korean black ginseng. Phytomedicine 54:169-181, 2019.
24. Muller WA. Leukocyte-endothelial cell interactions in the inflammatory response. Laboratory Investigation 82: 521-534, 2002.
25. Nakano M, Denda N, Matsumoto M, Kawamura M, Kawakubo Y, Hatanaka K, Harada Y. Interaction between cyclooxygenase (COX)-1-and COX-2-products modulates COX-2 expression in the late phase of acute inflammation. Eur J of Pharmacol 559:210-218, 2007.
26. Fausto MD, Jon Aster MD. Acute and chronic inflammation, 8th edition, (2009), Saunders Elsevier, Philadelphia.
27. Vane JR, Botting RM. The mechanism of action of aspirin. Thrombs Res 110:255-258, 2003.
28. Botting RM. Vane's discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology. Pharmacol Rep 62:518-525, 2010.
29. Swingle KF, Shideman FE. Phases of the inflammatory response to subcutaneous implantation of a cotton pellet and their modification by certain antiinflammatory agents. J Pharmacol Exp Ther 183:226-234, 1972.
30. Van der Veen BS, De Winther M P, Heeringa P. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 11:2899-2937, 2009.